SERA on Nasdaq

SERA PROGNOSTICS, INC.

American medical laboratories services company, incorporated in Delaware.

Price unavailable

Last updated Oct 18, 2026.

Overview

$81.0KRevenue, fiscal 20252
-$31.9MNet income, fiscal 20252

Compare with Aclarion, Inc., Advanced Biomed Inc. or YD Bio Ltd, or pick any stock.

  • TickerSERA on Nasdaq
  • IndustryServices-Medical Laboratories
  • HeadquartersDE
  • Incorporated inDE3
  • Business address2749 E. Parleys Way, Suite 200, Salt Lake City, Ut 841093
  • Filer category, Emerging growth company3

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

-45066.7%Operating margin2
-39417.3%Net margin2
5.2%Revenue growth, 20252
-42.3%Return on equity2
-$26.3MFree cash flow2

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue1¢$164.0K
  • Research and development99¢$13.2M
  • Interest0¢$9.0K

Out of $81.0K in revenue.2 The company lost money this year.

Financial statements

Revenue45672$81.0K in 2025+224% since 2020
0$100.0K$200.0K$300.0K$400.0K2020: $25.0K$25.0K20202021: $82.0K$82.0K2021+228%2022: $268.0K$268.0K2022+227%2023: $306.0K$306.0K2023+14%2024: $77.0K$77.0K2024−75%2025: $81.0K$81.0K2025+5%
Operating income45672-$36.5M in 2025+103% since 2020
-$60.0M-$40.0M-$20.0M02020: -$18.0M-$18.0M20202021: -$35.4M-$35.4M2021+97%2022: -$45.7M-$45.7M2022+29%2023: -$39.8M-$39.8M2023−13%2024: -$36.6M-$36.6M2024−8%2025: -$36.5M-$36.5M2025−0%
Net income45672-$31.9M in 2025+61% since 2020
-$60.0M-$40.0M-$20.0M02020: -$19.8M-$19.8M20202021: -$35.0M-$35.0M2021+76%2022: -$44.2M-$44.2M2022+26%2023: -$36.2M-$36.2M2023−18%2024: -$32.9M-$32.9M2024−9%2025: -$31.9M-$31.9M2025−3%

Every line of the income statement as filed: the last 2 fiscal years, latest first.2

Period ending2025-12-312024-12-31
Revenue$81.0K$77.0K
Cost of revenue$164.0K$82.0K
Research and development$13.2M$14.7M
Selling and marketing$6.5M$5.8M
General and administrative$16.7M$16.1M
Total operating expenses$36.6M$36.7M
Loss from operations-$36.5M-$36.6M
Interest expense-$9.0K-$28.0K
Other income, net$4.6M$3.8M
Net loss-$31.9M-$32.9M
Net loss per share, basic-$0.67-$0.99
Net loss per share, diluted-$0.67-$0.99
Weighted-average shares outstanding, basic47.7M shares33.2M shares
Weighted-average shares outstanding, diluted47.7M shares33.2M shares
Unrealized gain on available-for-sale debt securities, net of tax$202.0K$75.0K
Total other comprehensive income$202.0K$75.0K
Comprehensive loss-$31.7M-$32.8M

Compare SERA PROGNOSTICS, INC. with another company

Leadership

Who has led SERA PROGNOSTICS, INC., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Gregory C. Critchfield2021–2023
  2. Zhenya Lindgardt2023–now

Chief financial officer

  1. Jay M. Moyes2021–2023
  2. Austin Aerts2023–2026
  3. Scott Gleason2026–now
2025
Board members and other officers (19)

Timeline

  1. Nov 8, 2023New chief executive Zhenya Lindgardt becomes CEO12
  2. Jul 14, 2021New chief executive Gregory C. Critchfield becomes CEO13

Filings

596 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 53 major events, 292 insider forms, 25 large holders, 206 other. The latest 20:

  1. Oct 13, 20264 EDGAR
  2. Oct 13, 2026144 EDGAR
  3. Sep 11, 20264 EDGAR
  4. Sep 11, 2026144 EDGAR
  5. Sep 11, 20264 EDGAR
  6. Sep 11, 2026144 EDGAR
  7. Sep 11, 2026144 EDGAR
  8. Sep 11, 20264 EDGAR
  9. Sep 11, 2026144 EDGAR
  10. Sep 11, 20264 EDGAR
  11. Sep 11, 2026144 EDGAR
  12. Sep 9, 2026144 EDGAR
  13. Sep 9, 20264 EDGAR
  14. Sep 9, 2026144 EDGAR
  15. Sep 2, 20264 EDGAR
  16. Sep 1, 20264 EDGAR
  17. Sep 1, 20263 EDGAR
  18. Aug 19, 20268-K EDGAR
  19. Aug 12, 202610-Q EDGAR
  20. Aug 12, 20268-K EDGAR

The 596 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last three years, summarized. The full record is on SEC EDGAR.

Insider trades and holders

Large holders

Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 25 such filings since October 2021, the latest 10:

  1. Jul 15, 2026SCHEDULE 13G/A
  2. May 1, 2026SCHEDULE 13G/A
  3. Jan 16, 2026SCHEDULE 13G/A
  4. Sep 8, 2025SCHEDULE 13G
  5. Aug 14, 2025SCHEDULE 13G/A
  6. Aug 5, 2025SCHEDULE 13G
  7. May 15, 2025SCHEDULE 13G/A
  8. Feb 14, 2025SCHEDULE 13D/A
  9. Feb 14, 2025SCHEDULE 13D
  10. Nov 14, 2024SC 13G/A

From Forms 4 and Schedules 13D and 13G filed with the SEC.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 46. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Baker Bros. Advisors LP5,498,170$10.0M0.1%No change
Whetstone Capital Advisors, LLC3,306,889$6.0M1.6%No change
Aberdeen Group plc2,753,525$5.0M0.0%+202,750
Vivo Capital, LLC1,650,440$3.0M0.3%No change
Vanguard Capital Management LLC1,297,792$2.4M0.0%+93,677
Captrust Financial Advisors535,755$975.1K0.0%−1,006
Geode Capital Management, LLC348,967$635.5K0.0%−14,650
BlackRock, Inc.221,369$402.9K0.0%+25,264
AWM Investment Company, Inc.207,382$377.4K0.0%No change
Vanguard Fiduciary Trust Co170,908$311.1K0.0%+1,247
State Street Corp124,792$227.1K0.0%No change
Millennium Management LLC73,986$134.7K0.0%−17,518
Perigon Wealth Management, LLC72,685$132.3K0.0%No change
Northern Trust Corp68,595$124.8K0.0%−27,940
Bank of New York Mellon Corp60,927$110.9K0.0%No change
Bridgeway Capital Management, LLC55,705$101.4K0.0%+10,000
Requisite Capital Management, LLC55,648$101.3K0.0%No change
Morgan Stanley50,972$92.8K0.0%−54,045
Qube Research & Technologies Ltd50,871$92.6K0.0%+30,954
Ballentine Partners, LLC49,664$90.4K0.0%No change
Twelve Points Wealth Management LLC43,388$79.0K0.0%No change
HighTower Advisors, LLC42,234$76.9K0.0%No change
Citadel Advisors LLC41,411$75.4K0.0%−207,498
Catalyst Funds Management Pty Ltd38,890$70.8K0.0%+15,326
Goldman Sachs Group Inc32,541$59.2K0.0%+14,069

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34